Amgen's Psoriasis Drug Patents Are Valid, NJ Court Told
Amgen Inc. urged a New Jersey federal court on Wednesday to find that Sandoz Inc. and Zydus Pharmaceuticals Inc. infringed patents for the blockbuster plaque psoriasis medication Otezla, wrapping up a...To view the full article, register now.
Already a subscriber? Click here to view full article